ArticleMolecular therapy : the journal of the American Society of Gene Therapy2016

Superior Therapeutic Index in Lymphoma Therapy: CD30(+) CD34(+) Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack.

Andreas A Hombach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.